Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term tumor-necrosis-factor. Found 12 abstracts

Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappa B-independent, proteasome-mediated mechanism - art. no. 183. Molecular Cancer. 2010 Jul;9:183.   PMCID: PMC3044330
Younes A, Vose JM, Zelenetz AD, Smith MR, Burris HA, Ansell SM, Klein J, Halpern W, Miceli R, Kumm E, Fox NL, Czuczman MS. A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma. British Journal of Cancer. 2010 Dec;103(12):1783-7.   PMCID: PMCID: PMC3008610 [Available on 2011/12/7]
Yang HN, Bocchetta M, Kroczynska B, Elmishad AG, Chen YB, Liu ZM, Bubici C, Mossman BT, Pass HI, Testa JR, Franzoso G, Carbone M. TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappa B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2006 Jul;103(27):10397-402.
Tschoep K, Hartmann G, Jox R, Thompson S, Eigler A, Krug A, Erhardt S, Adams G, Endres S, Delius M. Shock waves: a novel method for cytoplasmic delivery of antisense oligonucleotides. Journal of Molecular Medicine-Jmm. 2001 Jun;79(5-6):306-13.
Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, Russo J, Sonenshein GE. Activation of NF-kappa B/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis. 2000 May;21(5):871-9.
Murthy S, Cooper HS, Yoshitake H, Meyer C, Meyer CJ, Murthy NS. Combination therapy of pentoxifylline and TNF alpha monoclonal antibody in dextran sulphate-induced mouse colitis. Alimentary Pharmacology & Therapeutics. 1999 Feb;13(2):251-60.
Bookman MA. Biological therapy of ovarian cancer: Current directions. Seminars in Oncology. 1998 Jun;25(3):381-96.
Berek JS, Martinezmaza O, Hamilton T, Trope C, Kaern J, Baak J, Rustin GJ. Molecular and Biological Factors in the Pathogenesis of Ovarian-Cancer. Annals of Oncology. 1993 Jan;4:3-16.
Bookman MA. Biologic Therapy in the Management of Refractory Ovarian-Cancer. Gynecologic Oncology. 1993 Oct;51(1):113-26.
Weiner LM, Holmes M, Richeson A, Godwin A, Adams GP, Hsiehma ST, Ring DB, Alpaugh RK. Binding and Cytotoxicity Characteristics of the Bispecific Murine Monoclonal Antibody-2b1. Journal of Immunology. 1993 Sep;151(5):2877-86.
Bookman MA, Berek JS. Biologic and Immunological Therapy of Ovarian-Cancer. Hematology-Oncology Clinics of North America. 1992 Aug;6(4):941-65.
Schultheiss TE, Stephens LC. Permanent Radiation Myelopathy. British Journal of Radiology. 1992 Sep;65(777):737-53.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term tumor-necrosis-factor

tumor-necrosis-factor cancer in-vitro expression phase-i trial epithelial-cells endothelial-cells colony-stimulating factor factor receptor expression single-chain fv activated crohns-disease killer-cells recombinant gamma-interferon prognostic- detection radiation factor-alpha inflammation lines trial immunohistochemical toxic lymphocytes-t rat spinal-cord murine b-cells transcription factor mice apoptosis-protein bispecific monoclonal- antisense oligonucleotide mouse model epidermal growth-factor white matter membrane permeabilization targets agonistic monoclonal-antibody cytokine release growth-factor induced apoptosis x-rays carcinoembryonic antigen complex-encoded antigens antibodies ca19-9 antigen etiology alpha human monocytes enhancement ca2 flow cytometric analysis radiolabeled monoclonal-antibody accelerated iap rabbit colitis immune colitis prognostic radiation myelopathy clinical-trial cell-death breast-cancer murine colitis mammalian-cells human inhibits significance constitutive production pulmonary fibrosis inflammation cancer-mesothelioma shock wave pleural mesothelial cells receptors trail-r1 ulcerative- untreated stage-iii radiation response apoptosis TRAIL-Apo2L vascular endothelial permeability oncogenes zinc target-cell radiotherapy tumor suppressor genes nude-mice il-1 pathogenesis lung-cancer apoptosis-inducing ligand ovarian cancer dna-ploidy cpg DNA ovarian-carcinoma activated killer-cells gynecologic oncology group streptococcal preparation ok-432 c-myc promoter chimeric monoclonal-antibody breast- tumor necrosis factor-alpha cellular dna content carcinoma ascitic fluid central-nervous-system inhibition human lymphocytes-t cationic lipids factors stage-i endothelial growth-factor monoclonal-antibody hmfg2 nk cells peripheral-blood lymphocytes malignancies gene-transfer phase-i evaluation cytokine production hybrid hybridomas oxpentifylline multiple-sclerosis mediated transfection x-linked-inhibitor hepatocellular-carcinoma cytosine-arabinoside phase-i inflammatory bowel-disease
Last updated on Wednesday, February 05, 2020